Diabetes Channel
Related Channels

Nesina Approval

Nesina® (alogliptin) is a prescription medicine used for controlling blood sugar levels in adults with type 2 diabetes. It works by decreasing the amount of sugar made by the liver and by increasing the amount of insulin produced in response to meals.
As a new medicine, Nesina received approval by the U.S. Food and Drug Administration (FDA) in January 2013. It belongs to a class of drugs called dipeptidyl peptidase-4 (DPP-4) inhibitors. Nesina contains the active component alogliptin. Alogliptin is also found in two combination diabetes medicines -- Kazano® (alogliptin and metformin) and Oseni® (alogliptin and pioglitazone).
Nesina comes as a tablet that is taken once a day. Although most people tolerate it well, side effects are possible and include headaches, a runny nose, and other symptoms of a common cold.
(Click Nesina for more information about this diabetes medicine, including a closer look at how it works.)
Steps to Prevent or Delay Diabetic Nerve Damage
Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2020 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.